In the present study, we found that cardiomyocyte-specific deletion of Piezo1 prevented activation of the CaMKII-HDAC4-MEF2 signaling pathway and reduced the amount of LVH developed after TAC by ~60%. The gene discussed is PIEZO1; the disease is persistent truncus arteriosus.